Related Experiment Video
Updated: Jul 10, 2026
04:19
A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
From Awareness to Action: Developing A Cystic Fibrosis-Tailored Screening for Disordered Eating Behaviors.
Jacob McCoy1, Megan Behrman2, Jade Robichaud2
1Albany Medical College, Albany, New York, United State of America.
Pediatric Pulmonology
|July 8, 2026
Summary
Healthcare professionals find managing disordered eating behaviors (DEB) in people with cystic fibrosis (CF) challenging due to limited resources and a lack of tailored screening tools. Developing a validated CF-specific screening tool is crucial for improving care.
Area of Science:
- Medical Research
- Nutrition Science
- Psychology
Background:
- Cystic Fibrosis (CF) is a chronic, diet-related condition.
- Individuals with CF have an increased risk of developing disordered eating behaviors (DEB) and eating disorders (ED).
- Unique DEB may manifest in people with CF (PWCF).
Purpose of the Study:
- To explore healthcare professionals' (HCP) experiences with DEB in PWCF.
- To understand the challenges HCP face in managing DEB within the CF population.
- To identify needs for improved DEB management strategies in CF care.
Main Methods:
- Qualitative interviews were conducted with 12 experienced HCP in CF care.
- Interviews explored eating behaviors, the impact of DEB, and management strategies for PWCF.
- Thematic analysis was used to interpret interview data.
Main Results:
- New weight-related challenges and stigma emerged with advanced CF therapies.
- HCP reported limited evidence-based guidance and resources for managing DEB in PWCF.
- Despite experience, HCP felt ill-equipped to address, manage, and treat DEB in PWCF.
Conclusions:
- A validated, CF-tailored screening tool for DEB in PWCF is currently lacking in the US.
- HCP express a need for better resources and training to manage DEB in the CF population.
- Developing a specific screening tool is critical for early identification and improved management of DEB in PWCF.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:28Anorexia Nervosa
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include: